4
Changes in Ownership
DEXCOM INC Filed Acc 0001093557-25-000288
Director sold 2,906 shares at $59.05 ($171,599)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Collins Richard Alexander Director | 2025-11-14 | Sale 10b5-1 | −2,906 | $59.05 | $171,599 | 35,088 | I: show line 1 in the form |
| Open-market sales · 2,906 sh · avg $59.05 · $171,599 | |||||||
Loading xslF345X05/wk-form4_1763419953.xml…